News on Medial

Related News

Lifetime Health raises $1.5 Mn in seed round

EntrackrEntrackr · 11m ago
Lifetime Health raises $1.5 Mn in seed round
Medial

Lifetime Health, a digital platform for at-home care, has secured $1.5 million in a seed round led by US-based venture capital firm The Garage Syndicate along with participation from other angel investors. The company had previously raised $900,000 in its last round from an existing investor. The fresh proceeds will be deployed towards further development, Lifetime Health said in a press release. Co-founded in 2023 by Konstantin Riabtsev, Michail Vorobiev and Nabil Ahmed, Lifetime Health is a digital platform for hospital-at-home care providing phlebotomy services, diagnostic tools, medical devices, nursing care, physiotherapy, and postoperative care all in one app. Its automated platform ensures fast, high-quality, and affordable service, from the client’s order to the nurse’s departure and results processing. Lifetime Health is currently operating in Bengaluru and its partner network includes 200 local clinics. It aims to reach major Indian cities and connect over 10,000 medical offices nationwide. intends to enable medical service orders at home for residents across Bangalore and its suburbs, and expand to Mumbai. The platform expects to have 1,000 doctors registered on the platform, with at least 300 of them becoming active users who can schedule appointments online, make appointments and recommendations, and maintain patient histories in digital format. The other startups in this space are Caresathome, CASAMED, Muse Diagnostic, Care24-India, and others.

Varco Leg Care raises $500K in Seed funding

EntrackrEntrackr · 1y ago
Varco Leg Care raises $500K in Seed funding
Medial

Delhi-based leg care brand Varco Leg Care has raised $500,000 (over Rs 4.5 crore) in Seed funding round led by Sunicon Maiden Fund, an early-stage venture fund curated by Sunicon Ventures. Prior to this, Varco Leg Care had raised a cumulative Rs 3.1 crore ($370,000) through its previous funding rounds. According to the company, its valuation has grown by 2x in the past 10 months. However, it did not disclose the numbers. Varco Leg Care will be utilizing the capital to strategically bolster capabilities across various fronts, which include enhancing offline touchpoints, advancing research and development (R&D) initiatives, and scaling and optimizing marketing efforts. Varco Leg Care aims to revolutionise leg health management by leveraging technology and clinical expertise. The firm has created a wide range of leg care products that address the end-to-end leg health needs of customers worldwide targeting health issues like varicose veins, diabetic foot, foot ulcer, and restless leg syndrome, among others. As per the company, it saw 110% increase in the brand’s revenue over the past year. Since its inception in 2022, Varco claims to have served more than 5 lakh customers, and expanded its presence to more than 3,000 medical stores across Mumbai, Bangalore, Delhi, and other Indian cities. Varco’s products are available at organised retail outlets such as Guardian Pharmacy, Noble Plus, Wellness Forever, and others. On the online front, it sells its products through its own website, as well as via marketplaces like Amazon, Flipkart, 1mg, and others.

Prantae Solutions saises seed round from IAN Group

EntrackrEntrackr · 5m ago
Prantae Solutions saises seed round from IAN Group
Medial

Deep-tech company Prantae Solutions has raised Rs 5 crore in a seed funding round led by the IAN Group, with participation from investors such as IAN Alpha Fund, Samir Kalia, Deepank Kumar, and Nitin Zamre. The fresh funds will be used to launch complementary diagnostic solutions for kidney health and diabetes care, enhance the product portfolio, and invest in research and development, Prantae Solutions said in a press release. Founded in 2015 by Sumona Karjee Mishra and Aseem Mishra, Prantae is a deep-tech-focused company emphasizing strong intellectual property and differentiated products. The company aims to transform healthcare into a realm of inclusivity and empowerment through next-generation diagnostic innovations. The Bhubaneswar-based company strives to break barriers in medical accessibility by developing cutting-edge, point-of-care solutions that deliver accurate, timely, and actionable insights. It is recognized for its commitment to innovation that enables early detection and proactive management of chronic conditions. According to market research, the point-of-care (POC) diagnostics market in India, valued at $1.41 billion in FY2024, is projected to grow at a CAGR of 8.47%, reaching $2.71 billion by FY2032. Globally, the market is expected to grow from $30.87 billion in 2023 to $51.19 billion by 2032. Prantae’s flagship product, Proflo-U, empowers kidney health assessment with its globally unmatched detection range for microalbumin to proteinuria levels. Powered by proprietary nanosensors, IoT, and AI technology, it offers calibration-free, cost-effective, and user-friendly testing solutions designed to improve patient outcomes and reduce healthcare costs. Prantae aims to establish a strong domestic presence before expanding to international markets. It also seeks to build highly differentiated point-of-care products and aspires to transform healthcare diagnostics, improving accessibility for millions worldwide.

Download the medial app to read full posts, comements and news.